Take in Non-CME Industry Symposia

The ATS encourages Non-CME Industry Symposia in conjunction with the International Conference. All full-conference participants are encouraged to attend these programs.


5:30 to 7 a.m.
San Francisco Marriott Marquis: Yerba Buena 9
Pulmonary Arterial Hypertension: Expert Forum

Pulmonary Arterial Hypertension: This expert Forum will open with an update on the current body of knowledge regarding the pathophysiology and treatment of PAH, followed by case-based presentations regarding PAH therapy. Within the case-based presentations, the expert panel will review how to select a first-line therapy for a patient, patient monitoring and clinical decision-making regarding treatment over time. Please visit booth 211 for more information.
Speaker: Vallerie McLaughlin, MD (Moderator), Professor of Internal Medicine and Director of the Pulmonary Hypertension Program, University of Michigan Health System, Ann Arbor
Organizer: Lung LLC


5:30 to 7 a.m.
San Francisco Marriott Marquis: Golden Gate B
Sedation in the ICU: Confronting Challenges and Applying Best Practices

Recent advances in assessment and management of pain, sedation and delirium in the ICU are explored in this timely symposium. The ABCDE system as well as the pending PAD guidelines will be discussed. The latest clinical findings, outcomes studies and practical methods of implementation will be presented by faculty who have been deeply involved in these clinical approaches.
Speakers: Juliana Barr, MD, FCCM (Chair), Associate Professor of Anesthesia, Stanford (Calif.) University School of Medicine; Timothy D. Girard, MD, MSCI, Assistant Professor of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.; and Yoanna Skrobik, MD, FRCPC, Professor in the Division of Critical Care, Maisonneuve Rosemont Hospital, University of Montreal, Quebec, Canada
Educational Grant Support: Hospira
Organizer: The France Foundation

6:30 to 9:30 p.m.
San Francisco Marriott Marquis: Golden Gate B
COPD Exacerbations: What Can We Do?

Chronic obstructive pulmonary disease (COPD) is associated with an enhanced inflammatory response in the airways and lungs, and exacerbations of the disease contribute to its progression. Newly revised GOLD guidelines for the management of COPD advocate a combined assessment approach based on symptom severity, level of airflow obstruction, and/or history of exacerbations. This symposium will focus on highlighting important revisions to the guidelines as well as reviewing treatment strategies that can benefit COPD patients.
Speakers: Stephen Rennard, MD (Chair), Larson Professor of Medicine, University of Nebraska Medical Center, Omaha; Sanjay Sethi, MD, Professor of Medicine and Chief of the Division Pulmonary, Critical Care and Sleep Medicine, University of Buffalo, and Section Chief for Pulmonary, Critical Care and Sleep Medicine, Veterans Affairs Western New York Healthcare System; and Gary Ferguson, MD, Director of the Pulmonary Research Institute of Southeast Michigan, Livonia
Organizer: Forest Pharmaceuticals, Inc.

6:30 to 9:30 p.m.
San Francisco Marriott Marquis Yerba Buena 7
The Pulmonary Personalized Medicine Challenge

The Pulmonary Personalized Medicine Challenge has been developed by the Johns Hopkins University School of Medicine. This program addresses knowledge/practice gaps regarding personalized medicine, genotyping and pharmacogenomics related to the treatment of asthma, NSCLC and CF. The symposium uses game-based methodologies designed to close knowledge/practice gaps related to personalized treatment of lung diseases.
Speakers: Michael Boyle, MD, FCCP, Associate Professor of Medicine and Director of the Adult Cystic Fibrosis Program, The Johns Hopkins University, Baltimore, Md.; Roy S. Herbst, MD, PhD, Professor of Medicine and of Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research, Yale School of Medicine, New Haven, Conn.; and Elliot Israel, MD, Professor of Medicine, Harvard Medical School, and Director of Clinical Research in the Pulmonary Division, Brigham and Women’s Hospital, Boston, Mass.
Educational Grant Support: Vertex Pharmaceuticals, Inc.
Organizer: The Johns Hopkins University in collaboration with DKBmed, LLC